Cambridge Innovation Capital (CIC) is a UK-based private equity firm that focuses on investing in research facilities, infrastructure, and technology companies. CIC typically participates in Series A and Series B funding rounds, supporting ventures with significant growth potential within the UK's robust science and technology ecosystem.
Notable portfolio companies include Nstream, Pretzel Therapeutics, and Seldon, which have collectively raised substantial funding. CIC's investment philosophy centers on leveraging their deep expertise and strategic position to identify and nurture transformative ideas. The firm offers unique value-add services by fostering close collaborations with pioneering entrepreneurs and scientists to drive impactful innovations.
Cambridge Innovation Capital - Portfolio Snapshot
Portfolio activity breakdown across disclosed investments and stages
Portfolio Companies3
Follow-on Investments2
Current Portfolio Count3
Top Investment Stages
Series A2 (50.0%)
Series B2 (50.0%)
Stage Mix
Series A 50%Series B 50%
Concentration shown as share of disclosed investments by stage.
Cambridge Innovation Capital - Classification
- Also Known As
- Cambridge Innovation Capital Manager Limited
- NAICS
- 520000Finance and Insurance
- 523000Securities, Commodity Contracts, and Other Financial Investments and Related Activities
- 523900Other Financial Investment Activities
- 523990All Other Financial Investment Activities
- 523999Miscellaneous Financial Investment Activities
- SIC
- 6700Holding And Other Investment Offices
- 6790Miscellaneous Investing
- 6799Investors, Not Elsewhere Classified
Show 6 more industry codes
- NAICS
- 525000Funds, Trusts, and Other Financial Vehicles
- 523910Miscellaneous Intermediation
- 523940Portfolio Management and Investment Advice
- SIC
- 6000Depository Institutions
- 6720Investment Offices
- 6722Management Investment Offices, Open-end
